<DOC>
	<DOC>NCT03034018</DOC>
	<brief_summary>The aim of this study is to determine the effect of suvorexant on insomnia symptoms in peri- and postmenopausal women who are experiencing sleep difficulties related to nighttime hot flashes.</brief_summary>
	<brief_title>Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Suvorexant</mesh_term>
	<criteria>Peri or postmenopausal women DSM5 criteria for Insomnia disorder, with onset of symptoms attributed to hot flashes Some awakenings cooccur with a hot flash Score on the Insomnia Severity Index (ISI) measure â‰¥15 Hot flashes present, including at night Diagnosis of other primary sleep disorders Shift workers Current or expected use of hypnotic medications Current major depressive episode Lifetime history of bipolar disorder, psychosis, or other serious mental health problem Current alcohol/substance use disorder Obesity Renal or hepatic disease Pregnancy or breastfeeding Recent malignancy Recent surgery Neurological disorder or cardiovascular disease raising safety concerns Medical instability considered to interfere with study procedures Concomitant medications with drug interaction or coadministration concerns Contraindications or allergic responses to suvorexant Recent or planned travel across time zones Excessive coffee or cigarette use</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>insomnia</keyword>
	<keyword>hot flashes</keyword>
	<keyword>menopause</keyword>
	<keyword>suvorexant</keyword>
	<keyword>belsomra</keyword>
</DOC>